The U.S. Army Medical Research and Materiel Command (USAMRMC) is looking to develop multiple immunochromatographic tests (ICTs) for the detection of infectious diseases and biological warfare agents (BWA).
USAMRMC has issued a pre-solicitation notice for a small business indefinite delivery indefinite quantity (ID/IQ) contract vehicle for potential activities including development of:
- Rapid Human Diagnostic Devices (RHDDs) for military-relevant IDs, including: dengue fever and dengue hemorrhagic fever, bacterial gastroenteritis, viral gastroenteritis
- Biological Warfare Agent (BWA) and related disease rapid diagnostics, such as brucellosis and western/eastern equine encephalitis viruses
- Arthropod Vector Rapid Detection Devices (AVRDDs) for military-relevant vector-borne diseases including but not limited to dengue virus, Leishmania species, and Plasmodium species
The contractor is required to have manufacturing facilities in compliance with Current Good Manufacturing Practice (cGMP) and will be the sponsor for the 510(k) of each ICT assay for the FDA.
The period of performance (POP) for the ID/IQ contract will be five years in duration, with one 12 month base period, accompanied by 4 twelve month option periods. Each Task Order issued under the ID/IQ for this requirement will have the potential to have a 4 year POP, depending on the advancement/development of the assays required.
Further details are available under Solicitation Number: W81XWH-15-R-0014.
